JUL 15, 2020 4:04 AM PDT

Mortality rate disparities in hospitals with different star ratings

The Center for Medicare and Medicaid Services' "Star Rating" system compares the quality of care of hospitals, rating hospitals with one to five stars based on 62 measurements such as mortality, readmissions, and patient experience. While not exactly like a Yelp review, this system is supposedly in place to help patients decide which hospitals best fit their medical needs. But does it actually do that? Some people think otherwise.

New research published in JNCI Cancer Spectrum reports a significant disparity in mortality rates for complex cancer procedures in one-star hospitals versus five-star hospitals. The findings speak to broader underlying disparities in healthcare that have been made evermore evident by the COVID-19 pandemic.

Medicare Supplement Plans

In conducting this study, the team analyzed data from 105,823 patients who underwent complex cancer procedures at 3,146 hospitals between 2013 and 2016. The group included patients over 65 years old with a diagnosis of cancer of the lung, colon, stomach, esophagus, or pancreas. The research found that mortality rates for complex cancer procedures in one-star hospitals are as high as 10.4% while five-star hospitals show rates of 6.4%.

"For complex cancer care, choosing the right hospital may be as important as choosing the right treatment.," said Daniel Boffa. "In order for patients to select the best hospital for their situation, they need access to understandable information regarding the safety and quality of hospital care. Unfortunately, the CMS star-rating system, while clear and easy to access, does not appear to distinguish the safest from the least safe hospitals with enough separation to reliably guide cancer patient choice for complex surgical care."

Photo: Pixabay

Additionally, the research team says that the overall effectiveness of the star rating system in helping patients choose hospitals for complex cancer surgeries appears to be modest. As the authors write, “Reassignment of patients from 1-star to 5-star hospitals (7.8% of patients) was predicted to save 84 Medicare beneficiaries each year. This impact varied by the procedure (colectomy: 47 lives/year to gastrectomy: 5 lives/year). Overall, 2,189 patients would have to change hospitals each year to improve outcomes (26 patients moved to save one life).”

So what are the other options that patients have? Scientists are still trying to figure that out.

Sources: JNCI Cancer Spectrum, Eureka Alert, Final Expense & Medicare Leads

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 11, 2021
Immunology
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
MAY 11, 2021
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
Researchers have discovered how a glitch in the brain’s immune system can inadvertently cause an accelerated growt ...
MAY 08, 2021
Cancer
More evidence supports the evils of sugary drinks
MAY 08, 2021
More evidence supports the evils of sugary drinks
New research published online in the journal Gut from researchers at the Washington University School of Medicine i ...
MAY 09, 2021
Cancer
Vegetarian diet shows low levels of disease-related biomarkers
MAY 09, 2021
Vegetarian diet shows low levels of disease-related biomarkers
Researchers from the University of Glasgow have conducted a study on biomarkers in order to glean more information on th ...
MAY 23, 2021
Neuroscience
Study Links Alcohol Consumption to a Decline in Brain Health
MAY 23, 2021
Study Links Alcohol Consumption to a Decline in Brain Health
Thinking of cracking open a cold one this weekend? Researchers from the University of Oxford have identified a connectio ...
MAY 28, 2021
Cancer
Does your birth control increase your risk of breast cancer?
MAY 28, 2021
Does your birth control increase your risk of breast cancer?
A study published recently in EMBO Molecular Medicine considers the biological impacts of progestins from hormonal contr ...
JUN 22, 2021
Cancer
Evaluating adverse effects of induction therapy for neuroblastoma
JUN 22, 2021
Evaluating adverse effects of induction therapy for neuroblastoma
A study published in the Journal of Clinical Oncology reports an evaluation of the chemotherapy treatment given to child ...
Loading Comments...